Age: 68 Independent Director since: 2008 Committee(s): Organization and Compensation Quality, Product Supply, and Technology Other Public Boards: Shoulder Innovations (since 2020) Intersect ENT, Inc. (2006 2017) Education: B.S. and M.B.A., College of Notre Dame Qualifications: Industry and Technology expertise gained through more than three decades in the medical device industry holding roles at companies such as Epicor Medical, Heartport, Inc., a public company that helped pioneer minimally-invasive cardiac surgery, and Baxter Edward enables Mr. Tansey to bring valuable industry knowledge to our Board. Additionally, his years of experience supporting early-stage medical device companies, including at Epicor Medical, Baxter Edward, and now at U.S. Venture Partners, where his focuses include the development of minimally invasive technologies, helps him contribute deep knowledge of technologies critical to our business. Chief Executive Officer experience gained through his service as CEO of Heartport enables him to share perspectives that are relevant to the Board s oversight responsibilities. Financial / Capital Markets expertise acquired through extensive experience at his current firm investing in the medical device, biotechnology and healthcare information technology sectors enable him to offer invaluable insights and perspectives regarding financial and capital markets. Experience: U.S. Venture Partners , a venture capital investment firm: Managing Partner (since 2014); Managing Member (2005 2014) Epicor Medical , a medical device company specializing in minimally invasive treatments for atrial fibrillation: President and Chief Executive Officer (2002-2004) Heartport , a medical device company that pioneered minimally invasive cardiac surgery technologies: President and Chief Executive Officer (1999-2001) Current and former director of many early-stage and private medical device and life science companies